During the past decade, AmBeNet GmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AmBeNet GmbH" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Menarini Group" with 1 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored, "Mylan Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AmBeNet GmbH" #1 collaborator was "Mylan Germany GmbH" with 1 trials as a collaborator, "Mylan Healthcare Sp. z o.o." with 1 trials as a collaborator, "Mylan Österreich GmbH" with 1 trials as a collaborator and "Valneva Austria GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AmBeNet GmbH" are "Obesity" (2 trials), "Cytomegalovirus Infection" (1 trials), "Hypercholesterolemia" (1 trials), "Knee Osteoarthritis" (1 trials) and "Lyme Disease" (1 trials). Many other conditions were trialed in "AmBeNet GmbH" in a lesser frequency.

Most popular intervention types in "AmBeNet GmbH" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tirzepatide" (3 trials), "Dulaglutide" (1 trials), "Fasitibant- high dose" (1 trials) and "Fasitibant- intermediate dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "AmBeNet GmbH" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "AmBeNet GmbH". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AmBeNet GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AmBeNet GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".